标题
Countering TRAIL Resistance in Melanoma
作者
关键词
-
出版物
Cancers
Volume 11, Issue 5, Pages 656
出版商
MDPI AG
发表日期
2019-05-13
DOI
10.3390/cancers11050656
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Promotion of TRAIL/Apo2L-induced apoptosis by low-dose interferon-β in human malignant melanoma cells
- (2019) Akira Kazaana et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors
- (2019) Xin Yu et al. PLoS One
- The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells
- (2019) Peiying Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Key Role of Reactive Oxygen Species (ROS) in Indirubin Derivative-Induced Cell Death in Cutaneous T-Cell Lymphoma Cells
- (2019) Marwa Soltan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma
- (2019) Biswajit Podder et al. CELL DEATH AND DIFFERENTIATION
- BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
- (2019) Erinna F. Lee et al. Cell Death & Disease
- The Clinical Trial Landscape for Melanoma Therapies
- (2019) Sonia Wróbel et al. Journal of Clinical Medicine
- TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies
- (2018) Adel Naimi et al. BIOMEDICINE & PHARMACOTHERAPY
- Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance
- (2018) Justin Kale et al. EMBO REPORTS
- Trends in incidence of thick, thin and in situ melanoma in Europe
- (2018) L. Sacchetto et al. EUROPEAN JOURNAL OF CANCER
- BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation
- (2018) Ganlu Deng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunology and Genetic of Leishmania infantum: The Role of Endonuclease G in the Apoptosis
- (2018) SeyedHossein Hejazi et al. Journal of Research in Medical Sciences
- Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
- (2018) Chloé I Charendoff et al. Jove-Journal of Visualized Experiments
- BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
- (2018) Nabanita Mukherjee et al. Cell Death & Disease
- MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells
- (2018) Lin Lin et al. Oncogenesis
- BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
- (2018) Delphine Merino et al. CANCER CELL
- Crucial role of reactive oxygen species (ROS) for the proapoptotic effects of indirubin derivative DKP-073 in melanoma cells
- (2018) Veselina Zhivkova et al. MOLECULAR CARCINOGENESIS
- Bax, Bak and beyond - mitochondrial performance in apoptosis
- (2017) Aida Peña-Blanco et al. FEBS Journal
- Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells
- (2017) Daniel Bauer et al. Cell Death & Disease
- Cell cycle regulation and anticancer drug discovery
- (2017) Bai Jingwen et al. Cancer Biology & Medicine
- IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis
- (2016) Philippos Perimenis et al. BMC CANCER
- Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM
- (2016) Leona Rohrbeck et al. CELL DEATH AND DIFFERENTIATION
- Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra
- (2016) Ammad Farooqi et al. CURRENT GENOMICS
- Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
- (2016) Claus Garbe et al. EUROPEAN JOURNAL OF CANCER
- Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia
- (2016) Christopher M. Doran et al. PLoS One
- Interleukin-2, Ipilimumab, and Anti-PD-1: Clinical Management and the Evolving Role of Immunotherapy for the Treatment of Patients With Metastatic Melanoma
- (2015) Tasha Hughes et al. CANCER BIOLOGY & THERAPY
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Promises and Challenges of Smac Mimetics as Cancer Therapeutics
- (2015) S. Fulda CLINICAL CANCER RESEARCH
- Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer
- (2015) Gopeshwar Narayan et al. GENES CHROMOSOMES & CANCER
- Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins
- (2015) Sandra-Annika Quast et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity
- (2015) L O'Leary et al. ONCOGENE
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BH3-only proteins - possible proapoptotic triggers for melanoma therapy
- (2014) Michael Plötz et al. EXPERIMENTAL DERMATOLOGY
- Targeted Therapy Resistance Mechanisms and Therapeutic Implications in Melanoma
- (2014) Guo Chen et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Systemic treatment for BRAF-mutant melanoma: where do we go next?
- (2014) Alexander M Menzies et al. LANCET ONCOLOGY
- Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy
- (2014) Nethia Mohana-Kumaran et al. Pigment Cell & Melanoma Research
- Death receptors as targets in cancer
- (2013) O Micheau et al. BRITISH JOURNAL OF PHARMACOLOGY
- The BH3-only protein BimL overrides Bcl-2-mediated apoptosis resistance in melanoma cells
- (2013) Michael Plötz et al. CANCER LETTERS
- Sensitization of melanoma cells for TRAIL-induced apoptosis by activation of mitochondrial pathways via Bax
- (2013) Sandra-Annika Quast et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Hydrogen peroxide induces cell death in human TRAIL-resistant melanoma through intracellular superoxide generation
- (2013) MIZUKI TOCHIGI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- RAF Inhibition Overcomes Resistance to TRAIL-Induced Apoptosis in Melanoma Cells
- (2013) Anja Berger et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc Receptors
- (2013) C. Gieffers et al. MOLECULAR CANCER THERAPEUTICS
- Vemurafenib Potently Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in BRAFV600E Melanoma Cells
- (2013) D. Beck et al. Science Signaling
- TRAIL on trial: preclinical advances in cancer therapy
- (2013) Daniel W. Stuckey et al. TRENDS IN MOLECULAR MEDICINE
- ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis
- (2013) S-A Quast et al. Cell Death & Disease
- Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax
- (2013) A Berger et al. Cell Death & Disease
- Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?
- (2012) C.M. Nijenhuis et al. CANCER TREATMENT REVIEWS
- Disruption of the VDAC2–Bak interaction by Bcl-xS mediates efficient induction of apoptosis in melanoma cells
- (2012) M Plötz et al. CELL DEATH AND DIFFERENTIATION
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1
- (2012) Daniela Senft et al. PLoS One
- General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC
- (2012) Sandra-Annika Quast et al. PLoS One
- Mutual Regulation of Bcl-2 Proteins Independent of the BH3 Domain as Shown by the BH3-Lacking Protein Bcl-xAK
- (2012) Michael Plötz et al. PLoS One
- Bax: Addressed to kill
- (2011) Thibaud T. Renault et al. BIOCHIMIE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
- (2011) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- 2-Methoxyestradiol induced bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation
- (2011) Hongbo Min et al. MOLECULAR CARCINOGENESIS
- Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist
- (2010) Thomas S. Griffith et al. APOPTOSIS
- Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative—Enhancement of both extrinsic and intrinsic apoptosis pathways
- (2010) Anja Berger et al. BIOCHEMICAL PHARMACOLOGY
- Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
- (2010) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis
- (2010) M Hörnle et al. ONCOGENE
- Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid
- (2010) S Schneider-Jakob et al. Cell Death & Disease
- New caspase-independent but ROS-dependent apoptosis pathways are targeted in melanoma cells by an iron-containing cytosine analogue
- (2009) Jeannine C. Franke et al. BIOCHEMICAL PHARMACOLOGY
- Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic Carcinoma
- (2009) M. Vogler et al. CANCER RESEARCH
- Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells
- (2009) V. N. Ivanov et al. CANCER RESEARCH
- Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP
- (2009) Frank K. Braun et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Oncogenic BRAFV600E inhibits BIM expression to promote melanoma cell survival
- (2008) Robert A. Cartlidge et al. Pigment Cell & Melanoma Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now